Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:43 AM
Ignite Modification Date:
2025-12-25 @ 2:43 AM
NCT ID:
NCT06308133
Eligibility Criteria:
Inclusion Criteria:
* Patients and stem cell donors who have been evaluated as suitable for PBSC apheresis and collection, either for autologous or allogenic use
* Patients and stem cell donors that have completed at least one CD34+ apheresis procedure at Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico in Milan.
* Age ≥16 years
Exclusion Criteria:
* Patients affected by Acute Lymphoblastic Leukemia
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT06308133
Study Brief:
Protocol Section:
NCT06308133